Taiwan Semiconductor
TSM
Alibaba
BABA
Adobe
ADBE
4
Cisco
CSCO
5
Apple
AAPL
US Stock MarketDetailed Quotes
TARA Protara Therapeutics
- 3.399
- -0.001-0.04%
Trading Apr 30 11:09 ET
131.12MMarket Cap-1.57P/E (TTM)
3.400High3.280Low111.29KVolume3.350Open3.400Pre Close371.24KTurnover0.35%Turnover RatioLossP/E (Static)38.58MShares10.48052wk High0.78P/B108.48MFloat Cap1.59552wk Low--Dividend TTM31.92MShs Float800.000Historical High--Div YieldTTM3.53%Amplitude1.040Historical Low3.335Avg Price1Lot Size
About Protara Therapeutics Company
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.
Company Profile
SymbolTARA
Company NameProtara Therapeutics
Listing DateOct 22, 2014
Issue Price10.00
Founded2006
CEOMr. Jesse Shefferman, PhD
MarketNASDAQ
Employees33
Fiscal Year Ends12-31
Address345 Park Avenue South,3rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-646-844-0337
Websitehttp://www.protaratx.com
Company Executives
- Name
- Position
- Salary
- Jesse Shefferman, PhD
- Chief Executive Officer, President and Director
- 1.79M
- Jacqueline Zummo, M.B.A.,M.P.H.,PhD
- Chief Scientific Operations Officer
- 1.21M
- Patrick Fabbio
- Chief Financial Officer
- 1.02M
- Leonardo Viana Nicacio, M.D.
- Chief Medical Officer
- --
- Luke M. Beshar
- Chairman of the Board
- 192.10K
- Cynthia Smith
- Independent Director
- 72.60K
- Gregory P. Sargen
- Independent Director
- 75.60K
- Barry P. Flannelly, Pharm.D.
- Independent Director
- 66.60K
- Dr. Roger J. Garceau,M.D.,F.A.A.P.
- Independent Director
- 91.60K
- Dr. Richard S. Levy,M.D.
- Independent Director
- 112.47K
- Dr. Michael Edward Solomon, PhD
- Independent Director
- 72.72K
- Dr. Jane Huang, M.D.
- Independent Director
- 85.60K
- Hannah Fry
- Controller
- --
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call